Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab

Journal of the Neurological Sciences

Volumn 340, Issue 1-2, 2014, Pages 109-111

  Valenzuela, Reuben Mari ^a   Pula, John H ^a   Garwacki, Dennis ^a   Cotter, John ^a   Kattah, Jorge C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cryptoccocal meningitis; Immune reconstitution inflammatory syndrome (IRIS); Multiple sclerosis (MS); Natalizumab; Progressive multifocal leukoencephalopathy (PML); Relapsing remitting MS

Indexed keywords

AMPHOTERICIN B; BETA INTERFERON; FLUCONAZOLE; FLUCYTOSINE; GLATIRAMER; METHYLPREDNISOLONE; NATALIZUMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; CAUCASIAN; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; CRYPTOCOCCAL MENINGITIS; DISEASE EXACERBATION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEADACHE; HOMONYMOUS HEMIANOPIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; JC VIRUS; LETHARGY; MALE; MENINGEAL CYST; MENTAL DETERIORATION; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OPTIC NERVE ATROPHY; PHYSICAL EXAMINATION; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; VISUAL ACUITY; VOMITING; WEAKNESS; WHITE MATTER; COMPLICATION; DRUG EFFECTS; FOLLOW UP; MENINGITIS, CRYPTOCOCCAL; PATHOLOGY;

ANTIBODIES, MONOCLONAL, HUMANIZED; CORPUS CALLOSUM; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84899995085     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.03.007     Document Type: Article

References (11)

1. E. Pucci, G. Giuliani, A. Solari, S. Simi, S. Minozzi, and C. Di Pietrantonj et al. Natalizumab for relapsing remitting multiple sclerosis Cochrane Database Syst Rev 10 Oct 5 2011 CD007621 10.1002/14651858.CD007621.pub2
2. C.H. Polman, P.W. O'Connor, E. Havrdova, M. Hutchinson, L. Kappos, and D.H. Miller et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 9 2006 899 910
3. T.W. West, and B.A. Cree Natalizumab dose suspension: are we helping or hurting Ann Neurol 68 2008 395 399 [?]
4. P.W. O'Connor, A. Goodman, L. Kappos, F.D. Lublin, D.H. Miller, and D.H. C. Polman et al. Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis Neurology 76 2011 1858 1865
5. A. Miravalle, R. Jensen, and R.P. Kinkel Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy Arch Neurol 68 2011 186 191
6. B.K. Kleinschmidt-Demasters, A. Miravalle, J. Schowinsky, J. Corboy, and T. Vollmer Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab J Neuropathol Exp Neurol 71 7 Jul 2012 604 617
7. S. Gheuens, D.R. Smith, X. Wang, D.C. Alsop, R.E. Lenkinski, and I.J. Koralnik Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS Neurology 78 18 May 1 2012 1390 1393 [Epub 2012 Apr 18]
8. V. Rigau, A. Mania, P. Béfort, B. Carlander, O. Jonquet, and H. Lassmann et al. Lethal multiple sclerosis relapse after natalizumab withdrawal Neurology 79 Oct 24 2012 2214 2216
9. Olaf Stuve, Christina M. Marra, Amit Bar-Or, Masaaki Niino, Petra D. Cravens, and Sabine Cepok et al. Altered CD4 +/CD8 + T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis Arch Neurol 63 2006 1383 1387
10. S.A. Shelburne III, J. Darcourt, A.C. White, S.B. Greenberg, R.J. Hamill, and R.L. Atmar et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy Clin Infect Dis 40 2005 1049 1052
11. S.A. Shelburne, F. Visnegarwala, J. Darcourt, E.A. Graviss, T.P. Giordano, and A.C. White et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy AIDS 19 2005 399 406